Age-related changes in human bone marrow-derived mesenchymal stem cells: Consequences for cell therapies

Mechanisms of Ageing and Development

Volumn 129, Issue 3, 2008, Pages 163-173

  Stolzing, A ^a   Jones, E ^b   McGonagle, D ^b,c   Scutt, A ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c CALDERDALE ROYAL HOSPITAL   (United Kingdom)

Author keywords

Aging; Heat shock proteins; Human mesenchymal stem cells; Oxidative damage; Senescence

Indexed keywords

CD45 ANTIGEN; PROTEIN P21; PROTEIN P53; REACTIVE OXYGEN METABOLITE;

ADOLESCENT; ADULT; AGED; AGING; ARTICLE; BONE MARROW CELL; CELL AGING; CELL COUNT; CELL PROLIFERATION; CHILD; COLONY FORMING UNIT; CONTROLLED STUDY; DONOR; EX VIVO STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NEWBORN; OXIDATIVE STRESS; PRIORITY JOURNAL; RELIABILITY; SENESCENCE;

ADOLESCENT; ADULT; AGING; APOPTOSIS; BIOLOGICAL MARKERS; BONE MARROW CELLS; CELL AGING; CELL COUNT; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MIDDLE AGED; OSTEOGENESIS; PHENOTYPE; REACTIVE OXYGEN SPECIES;

EID: 39149093357     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mad.2007.12.002     Document Type: Article

References (56)

1. Atadja P., Wong H., Garkavtsev I., Veillette C., and Riabowol K. Increased activity of p53 in senescing fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 8348-8352
2. Banfi A., Muraglia A., Dozin B., Mastrogiacomo M., Cancedda R., and Quarto R. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: implications for their use in cell therapy. Exp. Hematol. 28 (2000) 707-715
3. Basu S., Michaelsson K., Olofsson H., Johansson S., and Melhus H. Association between oxidative stress and bone mineral density. Biochem. Biophys. Res. Commun. 288 (2001) 275-279
4. Baxter M.A., Wynn R.F., Jowitt S.N., Wraith J.E., Fairbairn L.J., and Bellantuono I. Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells 22 (2004) 675-682
5. Blair H.C., Zaidi M., and Schlesinger P.H. Mechanisms balancing skeletal matrix synthesis and degradation. Biochem. J. 364 (2002) 329-341
6. Bonyadi M., Waldman S.D., Liu D., Aubin J.E., Grynpas M.D., and Stanford W.L. Mesenchymal progenitor self-renewal deficiency leads to age-dependent osteoporosis in Sca-1/Ly-6A null mice. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 5840-5845
7. Byun C.H., Koh J.M., Kim D.K., Park S.I., Lee K.U., and Kim G.S. Alpha-lipoic acid inhibits TNF-alpha-induced apoptosis in human bone marrow stromal cells. J. Bone Miner. Res. 20 (2005) 1125-1135
8. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120 (2005) 513-522
9. D'Ippolito G., Schiller P.C., Ricordi C., Roos B.A., and Howard G.A. Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J. Bone Miner. Res. 14 (1999) 1115-1122
10. Dennis J.E., and Caplan A.I. Differentiation potential of conditionally immortalized mesenchymal progenitor cells from adult marrow of a H-2Kb-tsA58 transgenic mouse. J. Cell Physiol. 167 (1996) 523-538
11. Digirolamo C.M., Stokes D., Colter D., Phinney D.G., Class R., and Prockop D.J. Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br. J. Haematol. 107 (1999) 275-281
12. Ebert R., Ulmer M., Zeck S., Meissner-Weigl J., Schneider D., Stopper H., Schupp N., Kassem M., and Jakob F. Selenium supplementation restores the antioxidative capacity and prevents cell damage in bone marrow stromal cells in vitro. Stem Cells 24 (2006) 1226-1235
13. Finkel T., and Holbrook N.J. Oxidants, oxidative stress and the biology of ageing. Nature 408 (2000) 239-247
14. Hara E., Tsurui H., Shinozaki A., Nakada S., and Oda K. Cooperative effect of antisense-Rb and antisense-p53 oligomers on the extension of life span in human diploid fibroblasts, TIG-1. Biochem. Biophys. Res. Commun. 179 (1991) 528-534
15. Hegner B., Weber M., Dragun D., and Schulze-Lohoff E. Differential regulation of smooth muscle markers in human bone marrow-derived mesenchymal stem cells. J. Hypertens. 23 (2005) 1191-1202
16. Im G.I., Jung N.H., and Tae S.K. Chondrogenic differentiation of mesenchymal stem cells isolated from patients in late adulthood: the optimal conditions of growth factors. Tissue Eng. 12 (2006) 527-536
17. Jang Y.K., Jung D.H., Jung M.H., Kim D.H., Yoo K.H., Sung K.W., Koo H.H., Oh W., Yang Y.S., and Yang S.E. Mesenchymal stem cells feeder layer from human umbilical cord blood for ex vivo expanded growth and proliferation of hematopoietic progenitor cells. Ann. Hematol. 85 (2006) 212-225
18. Jones E.A., English A., Kinsey S.E., Straszynski L., Emery P., Ponchel F., and McGonagle D. Optimization of a flow cytometry-based protocol for detection and phenotypic characterization of multipotent mesenchymal stromal cells from human bone marrow. Cytometry B Clin. Cytom. 70 (2006) 391-399
19. Justesen J., Stenderup K., Eriksen E.F., and Kassem M. Maintenance of osteoblastic and adipocytic differentiation potential with age and osteoporosis in human marrow stromal cell cultures. Calcif. Tissue Int. 71 (2002) 36-44
20. Kume S., Kato S., Yamagishi S., Inagaki Y., Ueda S., Arima N., Okawa T., Kojiro M., and Nagata K. Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone. J. Bone Miner. Res. 20 (2005) 1647-1658
21. Liu J.M., Zhao H.Y., Ning G., Zhao Y.J., Zhang L.Z., Sun L.H., Xu M.Y., and Chen J.L. Relationship between body composition and bone mineral density in healthy young and premenopausal Chinese women. Osteoporos. Int. 15 (2004) 238-242
22. Mackay A.M., Beck S.C., Murphy J.M., Barry F.P., Chichester C.O., and Pittenger M.F. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng. 4 (1998) 415-428
23. Maggio D., Barabani M., Pierandrei M., Polidori M.C., Catani M., Mecocci P., Senin U., Pacifici R., and Cherubini A. Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study. J. Clin. Endocrinol. Metab. 88 (2003) 1523-1527
24. Majors A.K., Boehm C.A., Nitto H., Midura R.J., and Muschler G.F. Characterization of human bone marrow stromal cells with respect to osteoblastic differentiation. J. Orthop. Res. 15 (1997) 546-557
25. Martinez P., Moreno I., De Miguel F., Vila V., Esbrit P., and Martinez M.E. Changes in osteocalcin response to 1,25-dihydroxyvitamin D(3) stimulation and basal vitamin D receptor expression in human osteoblastic cells according to donor age and skeletal origin. Bone 29 (2001) 35-41
26. Mauney J.R., Kaplan D.L., and Volloch V. Matrix-mediated retention of osteogenic differentiation potential by human adult bone marrow stromal cells during ex vivo expansion. Biomaterials 25 (2004) 3233-3243
27. Medrano S., and Scrable H. Maintaining appearances-the role of p53 in adult neurogenesis. Biochem. Biophys. Res. Commun. 331 (2005) 828-833
28. Mehlen P., Preville X., Chareyron P., Briolay J., Klemenz R., and Arrigo A.P. Constitutive expression of human hsp27, Drosophila hsp27, or human alpha B-crystallin confers resistance to TNF- and oxidative stress-induced cytotoxicity in stably transfected murine L929 fibroblasts. J. Immunol. 154 (1995) 363-374
29. Mody N., Parhami F., Sarafian T.A., and Demer L.L. Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radical Biol. Med. 31 (2001) 509-519
30. Morton J., Hutchins C., and Durrant S. Granulocyte-colony-stimulating factor (G-CSF)-primed allogeneic bone marrow: significantly less graft-versus-host disease and comparable engraftment to G-CSF-mobilized peripheral blood stem cells. Blood 98 (2001) 3186-3191
31. Murphy J.M., Dixon K., Beck S., Fabian D., Feldman A., and Barry F. Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis. Arthritis Rheum. 46 (2002) 704-713
32. Muschler G.F., Nitto H., Boehm C.A., and Easley K.A. Age- and gender-related changes in the cellularity of human bone marrow and the prevalence of osteoblastic progenitors. J. Orthop. Res. 19 (2001) 117-125
33. Nishida S., Endo N., Yamagiwa H., Tanizawa T., and Takahashi H.E. Number of osteoprogenitor cells in human bone marrow markedly decreases after skeletal maturation. J. Bone Miner. Metab. 17 (1999) 171-177
34. Nover L. HSFs and HSPs-a stressful program on transcription factors and chaperones. Stress Proteins and the Heat Shock Response, sponsored by Cold Spring Harbor Laboratory, Cold Spring Harbor, NY USA, April 29-May 2. New Biol. 3 (1991) 855-859
35. Oreffo R.O., Bennett A., Carr A.J., and Triffitt J.T. Patients with primary osteoarthritis show no change with ageing in the number of osteogenic precursors. Scand. J. Rheumatol. 27 (1998) 415-424
36. Oreffo R.O., Bord S., and Triffitt J.T. Skeletal progenitor cells and ageing human populations. Clin. Sci. (Lond.) 94 (1998) 549-555
37. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., and Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science (New York, NY) 284 (1999) 143-147
38. Renault V., Thornell L.E., Butler-Browne G., and Mouly V. Human skeletal muscle satellite cells: aging, oxidative stress and the mitotic clock. Exp. Gerontol. 37 (2002) 1229-1236
39. Rosso A., Balsamo A., Gambino R., Dentelli P., Falcioni R., Cassader M., Pegoraro L., Pagano G., and Brizzi M.F. p53 Mediates the accelerated onset of senescence of endothelial progenitor cells in diabetes. J. Biol. Chem. 281 (2006) 4339-4347
40. Roura S., Farre J., Soler-Botija C., Llach A., Hove-Madsen L., Cairo J.J., Godia F., Cinca J., and Bayes-Genis A. Effect of aging on the pluripotential capacity of human CD105+ mesenchymal stem cells. Eur. J. Heart Fail. 8 (2006) 555-563
41. Safford K.M., Hicok K.C., Safford S.D., Halvorsen Y.D., Wilkison W.O., Gimble J.M., and Rice H.E. Neurogenic differentiation of murine and human adipose-derived stromal cells. Biochem. Biophys. Res. Commun. 294 (2002) 371-379
42. Sethe S., Scutt A., and Stolzing A. Aging of mesenchymal stem cells. Ageing Res. Rev. 5 (2006) 91-116
43. Sher L.B., Woitge H.W., Adams D.J., Gronowicz G.A., Krozowski Z., Harrison J.R., and Kream B.E. Transgenic expression of 11beta-hydroxysteroid dehydrogenase type 2 in osteoblasts reveals an anabolic role for endogenous glucocorticoids in bone. Endocrinology 145 (2004) 922-929
44. Shindo K., Kawashima N., Sakamoto K., Yamaguchi A., Umezawa A., Takagi M., Katsube K., and Suda H. Osteogenic differentiation of the mesenchymal progenitor cells, Kusa is suppressed by Notch signalling. Exp. Cell Res. 290 (2003) 370-380
45. Shui C., and Scutt A. Mild heat shock induces proliferation, alkaline phosphatase activity, and mineralization in human bone marrow stromal cells and Mg-63 cells in vitro. J. Bone Miner. Res. 16 (2001) 731-741
46. Song H., Conte Jr. J.V., Foster A.H., McLaughlin J.S., and Wei C. Increased p53 protein expression in human failing myocardium. J. Heart Lung Transplant. 18 (1999) 744-749
47. Stein G.S., and Lian J.B. Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr. Rev. 14 (1993) 424-442
48. Stenderup K., Justesen J., Eriksen E.F., Rattan S.I., and Kassem M. Number and proliferative capacity of osteogenic stem cells are maintained during aging and in patients with osteoporosis. J. Bone Miner. Res. 16 (2001) 1120-1129
49. Stolzing A., Sethe S., and Scutt A.M. Stressed stem cells: temperature response in aged mesenchymal stem cells. Stem. Cells Dev. 15 (2006) 478-487
50. Szulc P., Kaufman J.M., and Delmas P.D. Biochemical assessment of bone turnover and bone fragility in men. Osteoporos Int. 18 (2007) 1451-1461
51. Tezuka K., Yasuda M., Watanabe N., Morimura N., Kuroda K., Miyatani S., and Hozumi N. Stimulation of osteoblastic cell differentiation by Notch. J. Bone Miner. Res. 17 (2002) 231-239
52. Torella D., Rota M., Nurzynska D., Musso E., Monsen A., Shiraishi I., Zias E., Walsh K., Rosenzweig A., Sussman M.A., Urbanek K., Nadal-Ginard B., Kajstura J., Anversa P., and Leri A. Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ. Res. 94 (2004) 514-524
53. Walters M.R., Fischette C.T., Fetzer C., May B., Riggle P.C., Tibaldo-Bongiorno M., and Christakos S. Specific 1,25-dihydroxyvitamin D3 binding sites in choroid plexus. Eur. J. Pharmacol. 213 (1992) 309-311
54. Wang X., Kua H.Y., Hu Y., Guo K., Zeng Q., Wu Q., Ng H.H., Karsenty G., de Crombrugghe B., Yeh J., and Li B. p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling. J. Cell Biol. 172 (2006) 115-125
55. Whiting S.J., Vatanparast H., Baxter-Jones A., Faulkner R.A., Mirwald R., and Bailey D.A. Factors that affect bone mineral accrual in the adolescent growth spurt. J. Nutr. 134 (2004) 696S-700S
56. Zheng H., Martin J.A., Duwayri Y., Falcon G., and Buckwalter J.A. Impact of aging on rat bone marrow-derived stem cell chondrogenesis. J. Gerontol. A Biol. Sci. Med. Sci. 62 (2007) 136-148